Changes in Myocardial Iron Content Following Administration of Intravenous Iron
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2018
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms Myocardial-IRON
- 28 Jul 2018 Status changed from recruiting to completed.
- 01 Apr 2018 The results will be available around October 2018.
- 01 Apr 2018 Patient enrollment started in May 2017. Till 31 December 2017, 25 patients were enrolled in the study.